company
Message from the President
Corporate Philosophy
Our Mission
We will contribute to the advancement of the healthcare industry by providing high-value-added solutions to our clients.
Our Vision
If we improve each day, we can progress ourselves daily, and will continue to do so.
EverProgressingSystem
Our Values
- For Our Clients
- We always place the highest priority on meeting clients’ needs and providing high-value-added services.
- For Our Business
- We will contribute to the advancement of society through sustained development of our busines.
- For Our People
- We will grow through our service to clients, and improve the quality of life (QOL) of all our stakeholders.
Corporate Profile
- Corporate Name
- EP Mediate Co., Ltd.
- Representative
- Masanori Tanji, President and Representative Director
- Headquarters
- Kagurazaka AK Building, 1-8 Tsukudocho, Shinjuku-ku, Tokyo, Japan
- Locations
-
- Tokyo
- Kagurazaka AK Building, 1-8 Tsukudocho, Shinjuku-ku, Tokyo, Japan
- Nagoya
- Nagoya Mitsui-Bussan Bldg., 1-16-21 Meiekiminami, Nakamura-ku, Nagoya-shi, Aichi, Japan
- Osaka
- Nomura Real Estate Development Osaka Bldg., 1-8-15 Azuchimachi, Chuo-ku, Osaka-shi, Osaka, 541-0052, Japan
- Saitama
- 2662 Tsuruma, Fujimi-shi, Saitama, Japan
- Establishment
- October 2018
- Capital
- 50 million yen
- Business Description
-
- Medical device development support business
- Foods with Health Claims development support business(Food CRO)
- In vitro diagnostic development support business
- Laboratory Business
- Employees
- 263 *As of October 1, 2023
- Parent Company
- EPS Corporation
Board Members Statutory Auditors
- Representative Director
- Masanori Tanji
- Director(Part-time)
- Takehisa Yamada
- Director(Part-time)
- Satoshi Okoso
- Director(Part-time)
- Masaaki Iseki
- Audit & Supervisory Board Member
- Masami Ito
Organization
- The Stockholders’ Meeting
- Auditor
- President and Representative Corporate Officer
- Business Planning Promotion Center
- Forecast Management Office
- Business Planning Promotion Office
- Sales Planning Office
- R&D Support Center
- Management Support Office
- R&D Support Office
- Medical Device Department
- Clinical Operations Section 1
- Clinical Operations Section 2
- Clinical Operations Section 3
- Clinical Operations Section 4
- IVD Promotion Section
- Regulatory Affair Section
- Medical device Development Section 1
- Medical device Development Section 2
- Foods Department
- Section 1
- Section 2
- Section 3
-
- Tsuruse Laboratory
- Quality Management Office
- Administration Department
Certification
EP Mediate has acquired the International Standard for Quality Management Systems "ISO 9001:2015/JIS Q 9001:2015" and the International Standard for Information Security Management Systems "ISO/IEC 27001:2013/JIS Q 27001:2014
Standards | ISO 9001:2015/JIS Q 9001:2015 | |
---|---|---|
Company Certified | EP Mediate Co., Ltd. | |
Scope | CRO service for drugs, medical devices, regenerative medicine and other products, and food for specified health use | |
Expiration Date | 8-DEC-2024 |
Standards | ISO/IEC 27001:2013/JIS Q 27001:2014 | |
---|---|---|
Company Certified | EP Mediate Co., Ltd. | |
Scope | CRO service for drugs, medical devices, regenerative medicine and other products, and food for specified health use | |
Expiration Date | 8-DEC-2024 |
Directions
Kagurazaka AK Building, 1-8 Tsukudocho, Shinjuku-ku, Tokyo, Japan
JR Chuo Line/Sobu Line: Iidabashi Station, West Exit, about 6-min walk
Tozai Line /Tokyo Metro Yurakucho Line/Namboku Line/Toei Oedo Line : Iidabashi Station, Exit B4b, about 3-min walk
EP Mediate was established in April 2020, after taking over the medical device development support business from EPS Corporation.
We have been expanding our business with one of the largest resources and services in Japan since we got started in 2002. In January 2021, in addition to our existing business, we merged Foods with Health Claims development support business(Food CRO)from TTC Group, in vitro diagnostic development support business from TRSS Co.,Ltd., and Laboratory Business, such as pharmaceutical formulation analysis business, and pharmacokinetic measurement business, etc., from Tsuruse laboratory, EPS Corporation.
Our business will be grown taking into consideration international expansion.
Pursuing our mission, we will contribute to the advancement of the healthcare industry by providing high-value-added solutions to our clients. We always keep our business vision, EPS stands for Ever Progressing System as our group company name, in mind and we will strive to provide the best possible service for our customers all the time.
We truly appreciate your continuous support and cooperation.
Masanori Tanji
President and Representative Director, EP Mediate Co., Ltd.